Rilonacept, takođe poznat kao IL-1 Trap i Arcalyst, je inhibotor interleukina 1.-{"The IL-1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, nonrandomized, single-blind pilot study " Oct 2009}--{Hoffman HM, Throne ML, Amar NJ, Cartwright RC, Kivitz AJ, Soo Y, Weinstein SP: Long-term efficacy and safety profile of rilonacept in the treatment of cryopryin-associated periodic syndromes: results of a 72-week open-label extension study. Clin Ther. .. Epub 2012 Sep 29. }--{Tran TH, Pham JT, Shafeeq H, Manigault KR, Arya V: Role of Interleukin-1 Inhibitors in the Management of Gout. Pharmacotherapy. 3.. }-Hawkins PN, Lachmann HJ, McDermott MF: Interleukin-1-receptor antagonist in the Muckle-Wells syndrome. N Engl J Med.
Reference
Literatura
Spoljašnje veze
-{Rilonacept}-
Категорија:Конструисани протеини Категорија:Имуномодулаторни лекови